Principal Financial Group
KPTI icon

Principal Financial Group’s Karyopharm Therapeutics KPTI Stock Holding History

Principal Financial Group’s Portfolio KPTI Stock Details KPTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,211
Closed -$50.1K – 2412
2024
Q1 		$50.1K Buy
2,211
+115
+5% +$2.02K ﹤0.01% 2345
2023
Q4 		$27.2K Sell
2,096
-93
-4% -$1.25K ﹤0.01% 2372
2023
Q3 		$44K Hold
2,189
– – ﹤0.01% 2354
2023
Q2 		$58.8K Sell
2,189
-1,068
-33% -$46K ﹤0.01% 2345
2023
Q1 		$190K Sell
3,257
-530
-14% -$26.2K ﹤0.01% 2190
2022
Q4 		$193K Buy
3,787
+2,465
+186% +$171K ﹤0.01% 2205
2022
Q3 		$109K Sell
1,322
-31
-2% -$2.31K ﹤0.01% 2320
2022
Q2 		$91K Buy
1,353
+479
+55% +$43.9K ﹤0.01% 2401
2022
Q1 		$97K Buy
874
+63
+8% +$7.85K ﹤0.01% 2428
2021
Q4 		$78K Sell
811
-1,213
-60% -$121K ﹤0.01% 2458
2021
Q3 		$176K Buy
2,024
+108
+6% +$11.2K ﹤0.01% 2449
2021
Q2 		$297K Sell
1,916
-214
-10% -$31.1K ﹤0.01% 2358
2021
Q1 		$336K Sell
2,130
-88
-4% -$18.5K ﹤0.01% 2246
2020
Q4 		$515K Buy
2,218
+651
+42% +$151K ﹤0.01% 2105
2020
Q3 		$344K Sell
1,567
-108
-6% -$26.4K ﹤0.01% 2103
2020
Q2 		$476K Buy
+1,675
New +$495K ﹤0.01% 1982
2014
Q2 		– Sell
-4,267
Closed -$1.98M – 2269
2014
Q1 		$1.98M Sell
4,267
-3,133
-42% -$1.59M ﹤0.01% 1657
2013
Q4 		$2.54M Buy
+7,400
New +$2.04M ﹤0.01% 1621

Other funds holding KPTI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Principal Financial Group's KPTI Position: Q2 2024 in Review

Principal Financial Group sold out of Karyopharm Therapeutics (KPTI) in Q2 2024, closing a stake of 2,211 shares — an estimated $50.1K sold.

Principal Financial Group first reported a position in KPTI in Q4 2013 and held it in 18 quarters. The position peaked at $2.54M in Q4 2013. 114 funds tracked by Wall St. Rank hold KPTI as of Q2 2024.

  • Principal Financial Group reported no remaining Karyopharm Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Principal Financial Group sold 2,211 Karyopharm Therapeutics shares in Q2 2024, an estimated $50.1K.
  • Principal Financial Group first reported a position in Karyopharm Therapeutics in Q4 2013 and held it in 18 quarters.
  • Principal Financial Group's Karyopharm Therapeutics position peaked at $2.54M in Q4 2013.
  • 114 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q2 2024.

Based on Principal Financial Group's 13F filing for Q2 2024, filed 29 Jul 2024.